Metalloproteinase inhibitor 3 (TIMP3) mRNA (TIMP3 mRNA)

Metalloproteinase inhibitor 3 (TIMP3) mRNA encodes a critical regulator of the extracellular matrix (ECM) that is unique among the TIMP family for its strong affinity for the ECM [3, 4]. The TIMP3 protein functions as a potent inhibitor of a wide range of matrix metalloproteinases (MMPs), ADAMs, and ADAMTSs, thereby controlling tissue remodeling, angiogenesis, and inflammatory signaling [1, 7]. The TIMP3 mRNA itself is characterized by an unusually long 3' untranslated region (UTR), which serves as a regulatory hub for numerous microRNAs, such as miR-21 and miR-221, that frequently downregulate its expression in pathological states [3, 11]. In oncology, reduced TIMP3 mRNA levels are associated with tumor invasion, metastasis, and poor prognosis, while mutations in the TIMP3 gene are the primary cause of Sorsby fundus dystrophy, a rare degenerative retinal disease [2, 5, 9]. Therapeutic strategies targeting TIMP3 mRNA include the use of antisense oligonucleotides and siRNAs to modulate expression in research settings, as well as the potential for mRNA-based replacement therapies to restore tumor-suppressive or cardioprotective functions [14, 17, 20]. Additionally, epigenetic modulators like DNA methyltransferase inhibitors are used to indirectly upregulate TIMP3 mRNA expression by reversing promoter hypermethylation [1, 11].

Other names

Tissue inhibitor of metalloproteinases 3 mRNATIMP-3 mRNAMetalloproteinase inhibitor 3 mRNASFD mRNA

RNA interference, antisense inhibition, mRNA replacement, and epigenetic induction of gene expression.